Tudor Investment Corp ET AL acquired a new stake in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 48,452 shares of the company's stock, valued at approximately $707,000. Tudor Investment Corp ET AL owned about 0.12% of Varex Imaging as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Earnest Partners LLC acquired a new position in Varex Imaging in the 4th quarter valued at $1,365,000. Aquatic Capital Management LLC acquired a new position in Varex Imaging in the fourth quarter valued at $25,000. Susquehanna Fundamental Investments LLC purchased a new position in Varex Imaging during the fourth quarter worth about $1,523,000. Price T Rowe Associates Inc. MD boosted its stake in Varex Imaging by 22.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,411 shares of the company's stock worth $225,000 after buying an additional 2,807 shares during the last quarter. Finally, Stifel Financial Corp purchased a new stake in Varex Imaging in the 4th quarter valued at about $457,000.
Analysts Set New Price Targets
VREX has been the topic of several recent analyst reports. Oppenheimer cut their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a report on Friday, February 7th. B. Riley reiterated a "buy" rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th. Finally, StockNews.com raised shares of Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th.
Check Out Our Latest Research Report on VREX
Varex Imaging Trading Down 20.5 %
Shares of NASDAQ VREX traded down $1.77 during midday trading on Friday, hitting $6.88. The stock had a trading volume of 951,429 shares, compared to its average volume of 572,589. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a 1-year low of $6.76 and a 1-year high of $16.93. The company has a market capitalization of $283.46 million, a price-to-earnings ratio of -5.88 and a beta of 0.62. The company has a fifty day moving average price of $9.87 and a 200 day moving average price of $12.71.
Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The firm had revenue of $212.90 million for the quarter, compared to analysts' expectations of $206.76 million. During the same period in the previous year, the company posted $0.16 earnings per share. Varex Imaging's revenue was up 3.3% compared to the same quarter last year. On average, analysts predict that Varex Imaging Co. will post 0.53 earnings per share for the current year.
Insider Buying and Selling at Varex Imaging
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the business's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now directly owns 4,002 shares of the company's stock, valued at approximately $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the firm's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the sale, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. The trade was a 4.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.
Varex Imaging Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
See Also

Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.